Survey - Allergic Rhinitis with Post-Nasal Drip - MontinaL-26-27MCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File Clinical Insight Mapping: “Allergic Rhinitis with Post-Nasal Drip: Real-World HCP Insights, Diagnostic Perspectives & Therapeutic Interventions”1. How frequently do your Allergic Rhinitis (AR) patients report Post-Nasal Drip (PND) as their most bothersome symptom? Over 75% of cases 50% – 75% of cases 25% – 50% of cases Less than 25%2. Which clinical sign most often prompts you to diagnose PND in your AR patients? Patient’s subjective "throat clearing" or "globus" sensation Visible "cobblestone" appearance in the posterior pharynx Chronic nocturnal cough Failure of standard nasal sprays to provide relief3. When PND persists despite antihistamine use, which underlying mechanism do you investigate first? Non-allergic/Vasomotor rhinitis (Neurogenic) Chronic Rhinosinusitis (Structural/Infectious) Laryngopharyngeal Reflux (LPR/Silent Reflux) Biofilm formation in the nasal mucosa4. How do you differentiate "Allergic PND" from "Vasomotor PND" in a clinical setting? Response to environmental triggers (Temperature/Smells) Presence of eosinophils in nasal cytology Response to a trial of Ipratropium Bromide IgE blood testing/Skin prick tests5. In your practice, how often is "Persistent PND" actually a symptom of LPR (Reflux) rather than Allergic Rhinitis? Very frequently (More than 40% of cases) Occasionally (10% – 30% of cases) Rarely (Less than 10% of cases)6. What is your preferred intervention for AR with persistent PND? Intranasal Corticosteroid (INCS) monotherapy Oral Montelukast + Levocetirizine combination Antihistamine + Oral Decongestant Nasal saline irrigation + INCS7. When antihistamine monotherapy fails, what is your immediate "Rethink" strategy for PND? Double the dose of the antihistamine Add a Leukotriene Receptor Antagonist (LTRA) Switch to an Intranasal Steroid/Antihistamine spray Add a systemic decongestant8. How do you rate the effectiveness of Montelukast + Levocetirizine specifically for reducing the "thickness" and "volume" of post-nasal secretions? Excellent (Significant reduction in secretions) Good (Satisfactory for most patients) Fair (Often requires adjunct therapy) Poor9. Rate the synergy of Montelukast + Levocetirizine in managing the "night-time" worsening of PND: Superior (Effective overnight control) Comparable to other therapies Effective only if taken twice daily10. Which class of medication do you find most effective for reducing the viscosity (thickness) of post-nasal mucus? Mucolytics (e.g., N-acetylcysteine) Leukotriene Receptor Antagonists (LTRAs) Oral Decongestants (Short-term) Saline sprays with buffering agents11. How do you view the role of Intranasal Anticholinergics (e.g., Ipratropium) in your holistic strategy? Essential for "watery" non-allergic rhinorrhea Useful as an add-on for refractory AR cases Rarely used due to side effect profile (Dryness)12. Rate the importance of "Nasal Hygiene" (Irrigation) compared to "Pharmacotherapy" in managing PND: Irrigation is the foundation of successful treatment Irrigation is a useful adjunct but secondary to drugs Minimal benefit for chronic PND patients13. At what point do you consider "Surgical Intervention" (e.g., Turbinate reduction or Sinus surgery) for persistent PND? After 3 months of failed maximal medical therapy Only if structural obstruction (Deviated Septum/Polyps) is present When PND is complicated by recurrent acute sinusitis I have read and agree to the Terms and Conditions .Submit Form